Dionissios Neofytos

Summary

Affiliation: Thomas Jefferson University
Country: USA

Publications

  1. doi request reprint Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry
    David L Horn
    Div of Infectious Diseases, Thomas Jefferson University, Ste 210, 211 S 9th St, Philadelphia, PA 19107, USA
    Clin Infect Dis 48:1695-703. 2009
  2. ncbi request reprint A case of recurrent episodes of Candida parapsilosis fungemia
    Dionissios Neofytos
    Division of Infectious Diseases and Environmental Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Mycopathologia 162:295-8. 2006
  3. ncbi request reprint Treatment of adenovirus disease in stem cell transplant recipients with cidofovir
    Dionissios Neofytos
    Division of Infectious Diseases and Environment Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Biol Blood Marrow Transplant 13:74-81. 2007
  4. ncbi request reprint Rhodotorula mucilaginosa catheter-related fungemia in a patient with sickle cell disease: case presentation and literature review
    Dionissios Neofytos
    Division of Infectious Diseases and Environmental Medicine, Thomas Jefferson University Hospital, 125 South 9th Street, Suite 403, Philadelphia, PA 19107, USA
    South Med J 100:198-200. 2007
  5. ncbi request reprint Emergence of staphylococcal cassette chromosome mec type IV methicillin-resistant Staphylococcus aureus as a cause of ventilator-associated pneumonia
    D Neofytos
    Division of Infectious Diseases and Environmental Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Infect Control Hosp Epidemiol 28:1206-9. 2007
  6. doi request reprint Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection
    Michael J Klevay
    Department of Medicine, University of Iowa, Iowa City, 52242, USA
    Diagn Microbiol Infect Dis 64:152-7. 2009
  7. doi request reprint Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007
    Heather L Nace
    Temple University School of Medicine, Philadelphia, PA 19140, USA
    Diagn Microbiol Infect Dis 64:289-94. 2009
  8. pmc Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients
    Carolyn D Alonso
    Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD 21205, USA
    Clin Infect Dis 54:1053-63. 2012
  9. doi request reprint Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry
    David Horn
    Thomas Jefferson University, Philadelphia, PA, USA
    Diagn Microbiol Infect Dis 63:384-7. 2009
  10. doi request reprint Candidemia in the 21st century
    Amy Chang
    Division of Infectious Diseases, Thomas Jefferson University, Suite 210, 211 South 9th Street, Philadelphia, PA 19107, USA
    Future Microbiol 3:463-72. 2008

Detail Information

Publications12

  1. doi request reprint Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry
    David L Horn
    Div of Infectious Diseases, Thomas Jefferson University, Ste 210, 211 S 9th St, Philadelphia, PA 19107, USA
    Clin Infect Dis 48:1695-703. 2009
    ..Candidemia remains a major cause of morbidity and mortality in the health care setting, and the epidemiology of Candida infection is changing...
  2. ncbi request reprint A case of recurrent episodes of Candida parapsilosis fungemia
    Dionissios Neofytos
    Division of Infectious Diseases and Environmental Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Mycopathologia 162:295-8. 2006
    ..The incidence of recurrent candidemia is likely to increase in the near future. Studies and therapeutic interventions for patients at risk for recurrent candidemias are warranted...
  3. ncbi request reprint Treatment of adenovirus disease in stem cell transplant recipients with cidofovir
    Dionissios Neofytos
    Division of Infectious Diseases and Environment Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Biol Blood Marrow Transplant 13:74-81. 2007
    ..In conclusion, early treatment of AdV disease with cidofovir inhibits viral replication in vivo and reduces mortality in allogeneic SCT recipients compared with historical data...
  4. ncbi request reprint Rhodotorula mucilaginosa catheter-related fungemia in a patient with sickle cell disease: case presentation and literature review
    Dionissios Neofytos
    Division of Infectious Diseases and Environmental Medicine, Thomas Jefferson University Hospital, 125 South 9th Street, Suite 403, Philadelphia, PA 19107, USA
    South Med J 100:198-200. 2007
    ..Rhodotorula mucilaginosa can be a significant, recalcitrant pathogen in immunocompromised patients and prompt treatment should be instituted...
  5. ncbi request reprint Emergence of staphylococcal cassette chromosome mec type IV methicillin-resistant Staphylococcus aureus as a cause of ventilator-associated pneumonia
    D Neofytos
    Division of Infectious Diseases and Environmental Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Infect Control Hosp Epidemiol 28:1206-9. 2007
    ..There were no significant differences in VAP severity and crude mortality rates between patients with SCCmec type II strains and patients with SCCmec type IV strains...
  6. doi request reprint Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection
    Michael J Klevay
    Department of Medicine, University of Iowa, Iowa City, 52242, USA
    Diagn Microbiol Infect Dis 64:152-7. 2009
    ..The lack of difference in mortality between species may reflect the overriding importance of host variables and/or a difference in virulence by species: further study is needed to investigate these hypotheses...
  7. doi request reprint Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007
    Heather L Nace
    Temple University School of Medicine, Philadelphia, PA 19140, USA
    Diagn Microbiol Infect Dis 64:289-94. 2009
    ..9% and 66.7%, respectively. In this contemporary sampling of patients with MSC, the combination of C. albicans/C. glabrata was most frequently observed and mortality was high...
  8. pmc Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients
    Carolyn D Alonso
    Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD 21205, USA
    Clin Infect Dis 54:1053-63. 2012
    ..A potentially important interplay between CDI and GVHD involving the gastrointestinal tract was observed...
  9. doi request reprint Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry
    David Horn
    Thomas Jefferson University, Philadelphia, PA, USA
    Diagn Microbiol Infect Dis 63:384-7. 2009
    ..Voriconazole was commonly administered (11/12; 91.7%), and 9 (75.0%) underwent surgery. Seven (58.3%) responded to treatment, and 12-week mortality was 25.0% (3/12). Survival was improved with surgical intervention (P = 0.05)...
  10. doi request reprint Candidemia in the 21st century
    Amy Chang
    Division of Infectious Diseases, Thomas Jefferson University, Suite 210, 211 South 9th Street, Philadelphia, PA 19107, USA
    Future Microbiol 3:463-72. 2008
    ..This review will focus on the changing epidemiology of candidal bloodstream infections, its impact on healthcare and new advances in the diagnosis and treatment of candidemia...
  11. ncbi request reprint Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections
    David L Horn
    Division of Infectious Diseases, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Diagn Microbiol Infect Dis 59:407-14. 2007
    ..As enrollment continues, additional data will be analyzed and published, which will provide valuable information concerning the epidemiology, therapy, and outcomes of IFIs...
  12. doi request reprint Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy
    Dionissios Neofytos
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Diagn Microbiol Infect Dis 75:144-9. 2013
    ..Host-related variables (demographics and baseline organ dysfunction) were identified as the most significant risk factors for IFI and mortality predictors in this series...